Works matching IS 14712474 AND DT 2014 AND VI 15 AND IP 1

Results: 777
    1
    2

    The 'Switch' study protocol: a randomisedcontrolled trial of switching to an alternative tumour-necrosis factor (TNF)-inhibitor drug or abatacept or rituximab in patients with rheumatoid arthritis who have failed an initial TNF-inhibitor drug.

    Published in:
    BMC Musculoskeletal Disorders, 2014, v. 15, n. 1, p. 834, doi. 10.1186/1471-2474-15-452
    By:
    • Coy, Nuria Navarro;
    • Brown, Sarah;
    • Bosworth, Ailsa;
    • Davies, Claire;
    • Emery, Paul;
    • Everett, Colin;
    • Fernandez, Catherine;
    • Gray, Janine;
    • Hartley, Suzanne;
    • Hulme, Claire;
    • Keenan, Anne-Maree;
    • McCabe, Christopher;
    • Redmond, Anthony;
    • Reynolds, Catherine;
    • Scott, David;
    • Sharples, Linda D.;
    • Pavitt, Sue;
    • Buch, Maya H.
    Publication type:
    Article
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43
    44
    45
    46
    47
    48
    49
    50

    Etanercept ameliorates inflammation and pain in a novel mono-arthritic multi-flare model of streptococcal cell wall induced arthritis.

    Published in:
    BMC Musculoskeletal Disorders, 2014, v. 15, n. 1, p. 63, doi. 10.1186/1471-2474-15-409
    By:
    • Chakravarthy, Kalyan;
    • Faltus, Robert;
    • Robinson, Gain;
    • Sevilla, Raquel;
    • Shin, John;
    • Zielstorff, Mark;
    • Byford, Alan;
    • Leccese, Erica;
    • Caniga, Michael J.;
    • Hseih, SuChun;
    • Shuli Zhang;
    • Chi-Sung Chiu;
    • Zhang-Hoover, Jie;
    • Moy, Lily Y.;
    • McLeod, Robbie L.;
    • Stoffregen, Dana;
    • Weisheng Zhang;
    • Murtaza, Anwar;
    • Cicmil, Milenko
    Publication type:
    Article